Dentists in Landover, MD Accepting Medicare
7 Dentists found. Showing 1 - 7
 Frewoin Meskele, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 7023 Martin Luther King Jr Hwy, Landover, MD 20785 Phone: 301-882-8888 |
 Rutvij Patel, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 7023 Martin Luther King Jr Hwy, Landover, MD 20785 Phone: 301-822-8888 |
Dr. James L Matthews, DDS Dentist Medicare: Medicare Enrolled Practice Location: 8444 Ardwick Ardmore Road, Landover, MD 20785 Phone: 301-322-3535 Fax: 301-322-8476 |
Dr. Michael Mendelson, DDS Dentist - Dental Public Health Medicare: Not Enrolled in Medicare Practice Location: 4351 Garden City Dr, Landover, MD 20785 Phone: 301-459-3650 |
Dr. Wilfred A Charles, D.D.S Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 8700 Central Ave, Suite 302, Landover, MD 20785 Phone: 301-350-9110 |
Dr. Pooja Soni Dentist Medicare: Not Enrolled in Medicare Practice Location: 7023 Martin Luther King Jr Hwy, Landover, MD 20785 Phone: 301-882-8888 |
Dr. Bert S Hall, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 7221 E Ridge Dr, Landover, MD 20785 Phone: 301-386-3533 |
News Archive
Study calls for continuous monitoring of dark web marketplaces in view of vaccines shortage
New research carried out by City data scientist, Dr. Andrea Baronchelli, and colleagues, into the dark web marketplace (DWM) trade in products related to COVID-19, has revealed the need for the continuous monitoring of dark web marketplaces (DWMs), especially in light of the current shortage and availability of coronavirus vaccines.
HIV positive man puts three women at risk
An HIV-positive man, John Choul Chan, 42, of Findon, South Australia, admitted to endangering the lives of three women through unprotected sex.
Titan Pharmaceuticals commences Phase 3 study of Probuphine for opioid addiction
Titan Pharmaceuticals, Inc. today announced the initiation of a randomized, placebo and active controlled, multi-center Phase 3 clinical study of Probuphine in the treatment of opioid addiction. This confirmatory Phase 3 study will be conducted at approximately 23 sites in the United States and randomize approximately 250 patients into three arms: Probuphine (100 patients), Suboxone® (100 patients) and placebo (50 patients).
Activity levels may distinguish unipolar from bipolar disorder
The measurement of activity levels may help distinguish patients with unipolar depression from those with bipolar disorder when they are in a remitted or mild/moderate depressive state, say researchers.
Drug resistance gene has spread from East Coast to Midwest
A resistance gene that allows bacteria to beat an important class of antibiotics has started to appear in microorganisms taken from Midwestern patients, according to researchers at Washington University School of Medicine in St. Louis.
› Verified 8 days ago
Counselors
Clinical Social Workers
Occupational Therapists
Dentists
Pharmacists
Psychologists